Blockade of leukotriene production by a single oral dose of MK‐0591 in active ulcerative colitis

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Clinical pharmacology and therapy

• Publication date

  1995-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0009-9236(95)90159-0PMID 7697951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory intermediaries in inflammatory bowel disease

  2005cited by this paper
• Pharmacokinetics and pharmacodynamics of multiple oral doses of MK‐0591, a 5‐lipoxygenase—activating protein inhibitor

  1994cited by this paper
• Selective 5‐lipoxygenase inhibition by zileuton in the treatment of relapsing ulcerative colitis: a randomized double‐blind placebo‐controlled multicentre trial

  1994cited by this paper
• Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses.

  1993cited by this paper
• Mucins in inflammatory bowel disease

  1993cited by this paper
• Studies of the inhibitory activity of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol- 2-yl]-2,2-dimethyl propanoic acid) on arachidonic acid metabolism in human phagocytes.

  1992cited by this paper
• Identification of the cystic fibrosis gene.

  1990cited by this paper
• Selective 5-lipoxygenase inhibition in ulcerative colitis.

  1990cited by this paper
• Preparation of leukotriene B4 antibodies in sheep.

  1989cited by this paper
• Measurement of urinary leukotrienes by reversed-phase liquid chromatography and radioimmunoassay.

  1989cited by this paper
• Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.

  1989cited by this paper
• In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis.

  1988cited by this paper
• In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.

  1987cited by this paper
• Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis.

  1986cited by this paper
• Enhanced formation of sulfidopeptide-leukotrienes in ulcerative colitis and Crohn's disease: inhibition by sulfasalazine and 5-aminosalicylic acid

  1986cited by this paper
• A double‐blind, placebo‐controlled trial

  1986cited by this paper
• Quantitation of sulfidopeptide leukotrienes by reversed-phase high-performance liquid chromatography.

  1985cited by this paper
• Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

  1984cited by this paper
• The role of arachidonic acid oxygenation products in pain and inflammation.

  1984cited by this paper
• Effect of carbenoxolone on gastric prostaglandin E2 levels in patients with peptic ulcer disease following vagal and pentagastrin stimulation

  1983cited by this paper
• Comparison of radioimmunological determinations with gas chromatography mass spectrometry dosage. A study of PGE2 and PGF2alpha in gastrointestinal fluids.

  1983cited by this paper
• Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978.

  1982cited by this paper
• Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils.

  1982cited by this paper
• Prostaglandin E2 in jejunal fluids and its potential diagnostic value for selecting patients with indomethacin‐sensitive diarrhoea

  1981cited by this paper
• Effect of various lipoxygenase metabolites of arachidonic acid on degranulation of polymorphonuclear leukocytes.

  1981cited by this paper
• The human PMN leukocyte chemotactic activity of complex hydroxy-eicosatetraenoic acids (HETEs).

  1980cited by this paper
• Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources.

  1980cited by this paper
• Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

  1980cited by this paper
• Leukotriene B: a potential mediator of inflammation

  1980cited by this paper
• Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A). Importance of the 11-cis-geometry for biological activity.

  1980cited by this paper
• Introduction of a nomenclature: leukotrienes.

  1979cited by this paper
• The Joint Assessment of Normality of Several Independent Samples

  1968cited by this paper
• Robust tests for equality of variances

  1961cited by this paper
• Contributions to Probability and Statistics

  1960cited by this paper

• Inhibiting Ferroptosis: A Novel Approach for Ulcerative Colitis Therapeutics

  2022cites this paper
• Emerging Pathological Engagement of Ferroptosis in Gut Diseases

  2021cites this paper
• Product Data Sheet Chemical Properties Product

  2016cites this paper
• Tetomilast: new promise for phosphodiesterase-4 inhibitors?

  2012cites this paper
• Boswellia serrata

  2011cites this paper
• Characterization of the cysteinyl leukotriene 2 receptor in novel expression sites of the gastrointestinal tract.

  2011cites this paper
• Colonic expression of leukotriene‐pathway enzymes in inflammatory bowel diseases

  2007cites this paper
• Der Einfluß von Sulfasalazin und seiner Metabolite auf die Leukotrien- und Thromboxansynthese in Monozyten und neutrophilen Granulozyten

  2006cites this paper
• Effects of Boswellia serrata in mouse models of chemically induced colitis.

  2005cites this paper
• 5-Lipoxygenase modulates colitis through the regulation of adhesion molecule expression and neutrophil migration

  2005cites this paper
• 30 Medical management of ulcerative colitis

  2003cites this paper
• Medical management of ulcerative colitis

  2003cites this paper
• Leukotrienes as targets in the gut

  2001cites this paper
• Acetyl-11-keto-β-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis

  2001cites this paper
• MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis.

  1999cites this paper
• Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be fully realized?

  1999cites this paper
• Leukotriene Binding, Signaling, and Analysis of HIV Coreceptor Function in Mouse and Human Leukotriene B4Receptor-transfected Cells*

  1999cites this paper
• Novel approaches to inflammatory bowel disease.

  1998cites this paper
• Soluble mediators and the interaction of drugs in IBD.

  1998cites this paper
• Pharmacokinetic and pharmacodynamic interaction between the lipoxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man.

  1998cites this paper
• Polymers for bioadhesion, absorption control and tissue separation

  1998cites this paper
• Leukotrienes in ulcerative colitis: results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591.

  1997cites this paper
• The efficacy of BAY y 1015 in dextran sulfate model of mouse colitis

  1997cites this paper
• A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis.

  1997cites this paper
• From basic science to future medical options for treatment of ulcerative colitis.

  1997cites this paper
• Recent developments in inflammatory bowel disease therapy

  1997cites this paper
• Mediators of inflammation in chronic inflammatory bowel disease.

  1996cites this paper